Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 37.


Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P
(2018) ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma. .


Faluyi, Olusola O, Connor, Joanna L, Chatterjee, Madhuchanda, Ikin, Carl, Wong, Helen and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre. BRITISH JOURNAL OF CANCER, 116 (04). pp. 424-431.


Vogel, Arndt, Frenette, Catherine, Sung, Max, Daniele, Bruno, Baron, Ari, Chan, Stephen L, Blanc, Jean Frederic, Tamai, Toshiyuki, Ren, Min, Lim, Howard J
et al (show 3 more authors) (2021) Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma. LIVER CANCER, 10 (5). pp. 510-521.


Childs, Alexa, Zakeri, Nekisa, Ma, Yuk Ting, O'Rourke, Joanne, Ross, Paul, Hashem, Essam, Hubner, Richard A, Hockenhull, Kimberley, Iwuji, Chinenye, Khan, Sam
et al (show 9 more authors) (2021) Biopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit. BRITISH JOURNAL OF CANCER, 125 (10). pp. 1350-1355.


Elmetwali, Taha, Salman, Asmaa, Wei, Wenbin, Hussain, Syed A, Young, Lawrence S and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2020) CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation. SCIENTIFIC REPORTS, 10 (1). 342-.


Primrose, John N, Fox, Richard P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Malik, Hassan Z, Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg
et al (show 19 more authors) (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. LANCET ONCOLOGY, 20 (5). pp. 663-673.


Backen, Alison C, Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G, Madhusudan, Srinivasan, Maraveyas, Anthony
et al (show 9 more authors) (2018) Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. British Journal of Cancer, 119 (1). pp. 27-35.


Jones, Christopher M, Radhakrishna, Ganesh, Aitken, Katharine, Bridgewater, John, Corrie, Pippa, Eatock, Martin, Goody, Rebecca, Ghaneh, Paula, Good, James, Grose, Derek
et al (show 8 more authors) (2020) Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position. BRITISH JOURNAL OF CANCER, 123 (5). pp. 709-713.


Evans, Jonathan P, Winiarski, Boleslaw K, Sutton, Paul A, Ressel, Lorenzo ORCID: 0000-0002-6614-1223, Duckworth, Carrie A ORCID: 0000-0001-9992-7540, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Goldring, Christopher E and Kitteringham, Neil R
(2019) Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research. LABORATORY ANIMALS, 53 (6). pp. 598-609.


Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L
et al (show 11 more authors) (2021) Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2. JHEP REPORTS, 3 (2). 100215-.


de Andres, Monica P, Jackson, Richard J, Felipe, Irene, Zagorac, Sladjana, Pilarsky, Christian, Schlitter, Anna Melissa, Martinez de Villareal, Jaime, Jang, Gun Ho, Costello, Eithne, Gallinger, Steve
et al (show 13 more authors) (2023) GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. GUT, 72 (3). pp. 535-548.


Hussain, Syed A, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Syn, Wing Kin, Sacco, Joseph J, Lloyd, Bryony, Jithesh, Puthen, Arrand, John R, Barton, Darren, Ansari, Jawaher, Sibson, David R
et al (show 1 more authors) (2013) Gene expression profiling in bladder cancer to identify potential therapeutic targets. JOURNAL OF CLINICAL ONCOLOGY, 31 (15). pp. 1147-1159.


Bhogal, Talvinder ORCID: 0000-0003-3297-9957, Khan, Umair T ORCID: 0000-0002-9470-3481, Lee, Rebecca, Stockdale, Alexander ORCID: 0000-0002-5828-3328, Hesford, Christian, Potti-Dhananjaya, Vaishnav, Jathanna, Avith, Rahman, Shaun, Tivey, Ann, Shotton, Rohan
et al (show 13 more authors) (2021) Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort. Leukemia & lymphoma, 62 (7). pp. 1-16.


Mahajan, Ujjwal Mukund, Langhoff, Eno, Goni, Elisabetta, Costello, Eithne, Greenhalf, William, Halloran, CM ORCID: 0000-0002-5471-4178, Ormanns, Steffen, Kruger, Stephan, Boeck, Stefan, Ribback, Silvia
et al (show 19 more authors) (2018) Immune Cell and Stromal Signature Associated with Progression-free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma. Gastroenterology, 155 (05). 1625-1639.E2.


Middleton, Gary, Greenhalf, William, Costello, Eithne, Shaw, Victoria ORCID: 0000-0002-0429-0186, Cox, Trevor, Ghaneh, Paula, Palmer, Daniel H ORCID: 0000-0002-7147-5703 and Neoptolemos, John P
(2016) Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma. British Journal of Cancer, 114 (5). pp. 510-518.


Sarker, Debashis, Plummer, Ruth, Meyer, Tim, Sodergren, Mikael H, Basu, Bristi, Chee, Cheng Ean, Huang, Kai-Wen, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ting, Yuk, Evans, TR Jeff
et al (show 26 more authors) (2020) MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial. CLINICAL CANCER RESEARCH, 26 (15). pp. 3936-3946.


McNamara, Mairead Geraldine, Goyal, Lipika, Doherty, Mark, Springfeld, Christoph, Cosgrove, David, Sjoquist, Katrin Marie, Park, Joon Oh, Verdaguer, Helena, Braconi, Chiara, Ross, Paul J
et al (show 5 more authors) (2020) NUC-1031/cisplatin versus gemcitabine/cisplatin in untreated locally advanced/metastatic biliary tract cancer (NuTide:121). FUTURE ONCOLOGY, 16 (16). pp. 1069-1081.


Halloran, Christopher, Neoptolemos, John P, Platt, Kellie, Jackson, Richard, Reddy, Srikanth, Oreily, Derek, Prachalias, Andreas, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Menon, Krishna, davidson, Brian
et al (show 2 more authors) (2020) PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results. .


Jones, Robert P ORCID: 0000-0001-5608-001X, Mielgo, Ainhoa, Schmid, Michael ORCID: 0000-0002-3445-0013, Bury, Danielle, Andrews, Timothy, Burdak-Rothkamm, Susanne ORCID: 0000-0002-3840-2844, Shackcloth, Michael, J. S. Cross, Timothy, Fenwick, Stephen, Malik, Hassan Z
et al (show 4 more authors) (2023) PINCER (A Platform Study for solId orgaN CancERs): an agile pan-network platform study to deliver high-quality translational research. BRITISH JOURNAL OF SURGERY, 110 (9). pp. 1108-1111.


Jones, Robert P ORCID: 0000-0001-5608-001X, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A
et al (show 92 more authors) (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154 (11). pp. 1038-1048.


Verset, Gontran, Borbath, Ivan, Karwal, Mark, Verslype, Chris, Van Vlierberghe, Hans, Kardosh, Adel, Zagonel, Vittorina, Stal, Per, Sarker, Debashis, Palmer, Daniel H ORCID: 0000-0002-7147-5703
et al (show 16 more authors) (2022) Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial. CLINICAL CANCER RESEARCH, 28 (12). pp. 2547-2554.


Ahmed, Ahmed A, Greenhalf, William ORCID: 0000-0002-1865-3195, Palmer, Daniel H, Williams, Nicole, Worthington, Jenny, Arshad, Tariq, Haider, Shozeb, Alexandrou, Effrosyni, Guneri, Dilek, Waller, Zoe AE
et al (show 1 more authors) (2023) The Potent G-Quadruplex-Binding Compound QN-302 Downregulates S100P Gene Expression in Cells and in an In Vivo Model of Pancreatic Cancer. MOLECULES, 28 (6). 2452-.


Burton, Anya, Balachandrakumar, Vinay K ORCID: 0000-0002-8906-2747, Driver, Robert J, Tataru, Daniela, Paley, Lizz, Marshall, Aileen, Alexander, Graeme, Rowe, Ian A, Palmer, Daniel H ORCID: 0000-0002-7147-5703 and Cross, Tim JS
(2022) Regional variations in hepatocellular carcinoma incidence, routes to diagnosis, treatment and survival in England. BRITISH JOURNAL OF CANCER, 126 (5). pp. 804-814.


Lamarca, Angela, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari
et al (show 11 more authors) (2021) Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. LANCET ONCOLOGY, 22 (5). pp. 690-701.


Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony
et al (show 8 more authors) (2017) Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8). pp. 565-575.


Palmer, Daniel H ORCID: 0000-0002-7147-5703, Valle, Juan W, Ting Ma, Yuk, Faluyi, Olusola, Neoptolemos, John P, Jensen Gjertsen, Trine, Iversen, Berit, Amund Eriksen, Jon, Moller, Anne-Sophie, Aksnes, Anne-Kirsti
et al (show 2 more authors) (2020) TG01/GM-CSF and adjuvant gemcitabine in patients with resected RAS-mutant adenocarcinoma of the pancreas (CT TG01-01): a single-arm, phase 1/2 trial. BRITISH JOURNAL OF CANCER, 122 (7). pp. 971-977.


Neoptolemos, John P, Kleeff, Joerg, Michl, Patrick, Costello, Eithne, Greenhalf, William and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2018) Therapeutic developments in pancreatic cancer: current and future perspectives. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 15 (6). pp. 333-348.


Rai, Zainab L, Ranieri, Veronica, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Littler, Peter, Ghaneh, Pauleh, Gurusamy, Kurinchi, Manas, Derek, Pizzo, Elena, Psarelli, Eftychia Eirini, Gilmore, Roopinder
et al (show 4 more authors) (2022) Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial. BMJ OPEN, 12 (5). e050166-.


Taieb, Julien, Seufferlein, Thomas, Reni, Michele, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Bridgewater, John A, Cubillo, Antonio, Prager, Gerald W, Vermeire, Alice, Hedouin-Biville, Fabienne, Teng, Zhaoyang
et al (show 1 more authors) (2023) Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe. BMC CANCER, 23 (1). 877-.


Hydes, Theresa J ORCID: 0000-0002-7768-6886, Cuthbertson, Daniel J ORCID: 0000-0002-6128-0822, Palmer, Daniel H, Elshaarawy, Omar, Johnson, Philip J ORCID: 0000-0003-1404-0209, Fernando, Rashika and Cross, Timothy J
(2023) Ultrasonography in surveillance for hepatocellular carcinoma in patients with non-alcoholic fatty liver disease. HEPATOMA RESEARCH, 9. p. 12.


Kudo, Masatoshi, Finn, Richard S, Edeline, Julien, Cattan, Stephane, Ogasawara, Sadahisa, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Verslype, Chris, Zagonel, Vittorina, Fartoux, Laetitia, Vogel, Arndt
et al (show 11 more authors) (2022) Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib. EUROPEAN JOURNAL OF CANCER, 167. pp. 1-12.


Ma, Yuk Ting, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. ONCOTARGET, 8 (38). pp. 63635-63645.


Ma, Yuk Ting, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. Oncotarget, 8 (38). pp. 63635-63645.


Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony ORCID: 0000-0001-8547-1730, Shaw, Victoria E ORCID: 0000-0002-0429-0186, Wadsley, Jonathan, Valle, Juan W
et al (show 14 more authors) (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18 (4). pp. 486-499.


Loughney, Lisa, West, Malcolm A, Moyses, Helen, Bates, Andrew, Kemp, Graham J, Hawkins, Lesley, Varkonyi-Sepp, Judit, Burke, Shaunna, Barben, Christopher P, Calverley, Peter M
et al (show 5 more authors) (2021) The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial). PERIOPERATIVE MEDICINE, 10 (1). 23-.


Aughton, Karen ORCID: 0000-0002-5184-5789, Elander, Nils O, Evans, Anthony ORCID: 0000-0001-8547-1730, Jackson, Richard, Campbell, Fiona, Costello, Eithne, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Mackey, John R, Scarfe, Andrew G, Valle, Juan W
et al (show 16 more authors) (2021) hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13 (22). 5758-.


Meyer, Tim, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Cheng, Ann-Lii, Hocke, Julia, Loembe, Arsene-Bienvenu and Yen, Chia-Jui
(2017) mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib. LIVER INTERNATIONAL, 37 (07). pp. 1047-1055.

This list was generated on Sat Mar 2 16:55:57 2024 GMT.